EIF4E and cancer: Hyperactive eIF4E-dependent translation plays a central role in reprogramming the proteome in cancer cells by supporting the translation of a subset of “eIF4E-sensitive” or “weak” mRNAs with low translation efficiency due to long, structured 5′-UTRs (1, 8).